No. of Recommendations: 1
OSI Pharmaceuticals

NEW YORK (CBS.MW) - Shares of OSI Pharmaceuticals more than doubled Monday as investors cheered positive clinical news about Tarceva, the company's treatment for relapsed non-small cell lung cancer....

Gapped ~$46 to open at $84. (!!)

Carrying some others with it. Evidently, DNA and ABGX are benefiting.


Print the post  


What was Your Dumbest Investment?
Share it with us -- and learn from others' stories of flubs.
When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.